Sign Up Today and Learn More About Amalgam Rx Stock
Invest in or calculate the value of your shares in Amalgam Rx or other pre-IPO companies through EquityZen's platform.

Amalgam Rx Stock (AMRX)
Amalgam Rx is a digital health company that combines clinical and behavioral interventions to support patients, providers, & life sciences.
About Amalgam Rx Stock
Founded
2016
Headquarters
Wilmington, DE, US
Industries
Software, Science and Engineering, Sales and Marketing
Amalgam Rx Press Mentions
Stay in the know about the latest news on Amalgam Rx
US Healthcare Analytics Market worth US$47.40 billion by 2029 with 24.5% CAGR | MarketsandMarkets™.
globenewswire • Apr 22, 2025
Amalgam Rx on LinkedIn: #valuebasedcare #providerengagement #ehr #emr
linkedin • Aug 05, 2024
Entrepreneur Of The Year Gulf South finalists
linkedin • Aug 05, 2024
Amalgam Rx Receives Strategic Investment From CVS Health Ventures
pulse2 • Oct 14, 2023
Amalgam Rx picks up Geetha's conversational AI tool
mobihealthnews • May 24, 2021
Amalgam Rx Management
Leadership team at Amalgam Rx
CMO
Suzanne Sysko Clough
CEO
Ryan Sysko

Join now and verify your accreditation status to gain access to:
- Amalgam Rx Current Valuation
- Amalgam Rx Stock Price
- Amalgam Rx Management
- Available deals in Amalgam Rx and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Amalgam Rx Cap Table and Funding History by Share Class and Liquidity Preferences
- Amalgam Rx Revenue and Financials
- Amalgam Rx Highlights
- Amalgam Rx Business Model
- Amalgam Rx Risk Factors
- Amalgam Rx Research Report from SACRA Research
Trading Amalgam Rx Stock
How to invest in Amalgam Rx stock?
Accredited investors can buy pre-IPO stock in companies like Amalgam Rx through EquityZen funds. These investments are made available by existing Amalgam Rx shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Amalgam Rx stock?
Shareholders can sell their Amalgam Rx stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."